KLYG (Kelyniam Global) Research & Development: $0.00 Mil (TTM As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Research & Development?

Kelyniam Global KLYG +4.82% Research & Development is $0.00 Mil as of Mar. 2008.

Research & Development is the aggregate amount of research and development expenses during the year. Kelyniam Global's Research & Development for the three months ended in Mar. 2008 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2008 was $0.00 Mil.

Kelyniam Global  (OTCPK:KLYG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kelyniam Global Research & Development Related Terms

Kelyniam Global Research & Development Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Research & Development Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Research & Development
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Kelyniam Global Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Kelyniam Global (KLYG) has a Research & Development of $0.00 Mil as of Mar. 2008. Research and development expense is the total cost for research and development activities. View historical data on Kelyniam Global and its competitors.
Is Kelyniam Global's Research & Development too high?
Kelyniam Global's current Research & Development is $0.00 Mil.
How does Kelyniam Global's Research & Development compare to VASO and WCUI?
Kelyniam Global's Research & Development of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kelyniam Global and its competitors. Kelyniam Global's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Research & Development is $0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.